Generics, specialty drugs drive AmerisourceBergen’s Q1
VALLEY FORGE, Pa. — AmerisourceBergen on Friday reported revenue of $19.9 billion, up 2.9%, for the first quarter ended Dec. 31.
"In the December quarter, we delivered outstanding performance on top of exceptional performance last year,” stated David Yost, AmerisourceBergen CEO. “We had strong results in all of our business units, we benefited from successful generic drug launches and we continued to demonstrate expense and working capital discipline,” he said. "Our balance sheet remains strong, and we continue to have excellent financial flexibility. We are off to a solid start for the fiscal year, demonstrating the strength of our two growth drivers — generics and specialty pharmaceuticals."
AmerisourceBergen reaffirmed its expectations for fiscal year 2011 diluted earnings per share in the range of $2.31 to $2.41.
Village Fertility Pharmacy promotes its Web-based forum with campaign
WALTHAM, Mass. — A specialty pharmacy focused on infertility is sponsoring a giveaway campaign to attract patients to its Web-based forum.
Village Fertility Pharmacy announced Thursday that users of its Village Voices site, an online forum and repository for infertility patients to post stories and share experiences launched in late 2010, will be eligible to win weekly giveaways through the month of February. Any user who submits a story or comments on a story will be entered to win a $30 gift card for use at the pharmacy.
“As a pharmacy staff that has worked with fertility patients for 25 years, we know how lonely the journey can be and how important it is for patients to hear — and become inspired by — other people’s fertility stories,” Village Fertility Pharmacy pharmacist and co-founder Stuart Levine said.
Elite granted FDA approval for generic Adipex-P
NORTHVALE, N.J. — The Food and Drug Administration has approved a generic weight-loss drug made by Elite Pharmaceuticals.
Elite announced Friday the approval of phentermine hydrochloride in the 37.5-mg strength, a generic version of Teva’s Adipex-P.
Branded and generic versions of the drug had sales of around $40 million in 2010, according to Elite.